Target intelligence / Profile preview

HIV-1 nucleocapsid protein (NCp7) (NCp7)

Target
NCp7
Molecular classification
Zinc finger protein, RNA-binding protein, Nucleic acid chaperone, Viral structural protein
01

Overview

The HIV-1 nucleocapsid protein (NCp7) is a small, basic protein containing two highly conserved CCHC-type zinc finger domains, often referred to as zinc knuckles (NIH, 2018). These domains are critical for the virus's life cycle, performing essential roles in the selection and packaging of genomic RNA into budding virions and acting as a nucleic acid chaperone to facilitate reverse transcription (Wikipedia, 2024; NIH, 2018). Because the CCHC motifs are invariant across nearly all retroviruses and are highly resistant to mutations that would preserve function, they represent an attractive therapeutic target (Grantome, 2024). Drugs targeting these domains, known as zinc finger inhibitors or zinc ejectors, work by covalently modifying the cysteine residues that coordinate the zinc ion, causing the ion's release and the subsequent unfolding of the protein (ACS, 1998). This disruption effectively halts viral replication and produces non-infectious viral particles, offering a strategy that may overcome resistance to traditional protease and reverse transcriptase inhibitors (PNAS, 1998).

Other names
NCp7Nucleocapsid protein p7NCGag-p7Zinc knuckle domains of HIV-1 NCCCHC-type zinc finger domains
02

Mechanism of action

Zinc ejection through covalent modification of the CCHC zinc-coordinating cysteine residues, leading to protein denaturation and loss of nucleic acid chaperone and packaging functions (Wikipedia, 2024; ACS, 1998).

03

Biological functions

Viral RNA packagingNucleic acid chaperoningReverse transcription facilitationViral assembly and buddingStrand transfer catalysis
04

Disease associations

HIV infectionAcquired Immunodeficiency Syndrome (AIDS)
05

Safety considerations

Potential off-target effects on human zinc finger proteins such as PARP or transcription factors (ACS, 1998)Systemic toxicity associated with electrophilic 'zinc ejector' compounds (ResearchGate, 2010)In vivo instability due to reactivity with cellular thiols like glutathione (Wikipedia, 2024)
06

Interacting drugs

Azodicarbonamide (ADA)

5 more in the full profile.

07

Biomarkers

HIV-1 viral load (plasma RNA levels)CD4+ T-lymphocyte count

Beyond the preview

Go deeper on HIV-1 nucleocapsid protein (NCp7) (NCp7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 nucleocapsid protein (NCp7) (NCp7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call